GTI Boosts Borrowing by $50 Million
Green Thumb Industries (GTI) increased its borrowing capacity by $50 million, strengthening its balance sheet for growth and operations.
Three of the Best Marijuana Strains for Battling Inflammation
A rundown of three cannabis strains that are often cited for their potential anti-inflammatory and wellness-related effects.
Curaleaf Borrows $500 Million for 3 Years at 11.5%
Curaleaf secured a $500 million three-year loan at 11.5% interest, adding liquidity for expansion and debt management in a high-rate environment.
Multi-State Operator Expansion Costs Mount as Market Consolidation Looms
As multi-state cannabis operators continue aggressive expansion strategies, operational costs are rising faster than revenue growth in many markets. Industry analysts warn that the easy growth phase…
Organigram’s German Ambitions Face Regulatory Headwinds
While Organigram’s acquisition of Germany’s Sanity Group positions the Canadian producer in one of Europe’s fastest-growing medical cannabis markets, integration challenges and regulatory…
The Hidden Cost of Curaleaf’s Borrowing Binge: Market Risk Rising
Curaleaf’s recent \$500 million three-year loan at 11.5% interest reveals a troubling truth: the market is pricing in real default risk for the cannabis industry’s largest MSO. While the capital…
Canopy Growth: When Dilution Disguises Desperation
Canopy Growth’s capital raises via warrant issuances continue a troubling pattern: the company dilutes existing shareholders to fund acquisitions that have failed to generate returns. Investors…
Congress Eyes Cannabis Legalization in 2026: What It Could Mean
Federal cannabis legalization may finally be on the horizon—2026 could be the year the industry gets real clarity and capital flows normalize.
Canopy Growth Technical Analysis: Dead Cat or Bounce?
Canopy Growth’s recent price action shows classic dead-cat bounce characteristics. At $1.12, the stock is testing resistance that has failed multiple times over the past 18 months. Technical traders…
Sanity Group Synergies: Where the Real Value Hides
Organigram’s €227M commitment to Sanity Group assumes meaningful synergies on the back end. Analysis of Sanity’s German operations reveals cost consolidation opportunities, but regulatory and…